Life ScienceCompany
Medivir M&A Summary
Medivir has acquired 4 companies. It has also divested 2 assets.
Medivir’s largest acquisition to date was in 2016, when it acquired TetraLogic Pharmaceuticals - Oncology Programs for $12M. It’s largest disclosed sale occurred in 2016, when it sold Biophausia AB to Karo Pharma AB for $107M. Medivir has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include life science (75%) and consumer products (25%).
Medivir Business Overview
Where is Medivir headquartered?
Medivir is headquartered in Huddinge, Sweden.
What is Medivir’s revenue?
Medivir disclosed revenue of 4M SEK for 2022 and 26M SEK for 2021.
How many employees does Medivir have?
Medivir has 9 employees.
What sector is Medivir in?
Medivir is a life science company.
When was Medivir founded?
Medivir was founded in 1987.
M&A Summary
-
M&A Total Activity6
- M&A Buy Activity4
- M&A Sell Activity2
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 3
- M&A Advisors 2
Unlimited Searches
